| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19529612ADE19529612A1 (en) | 1995-08-11 | 1995-08-11 | Sulfonyl or sulfinyl benzoylguanidine derivatives |
| Publication Number | Publication Date |
|---|---|
| HU9602196D0 HU9602196D0 (en) | 1996-10-28 |
| HUP9602196A2 HUP9602196A2 (en) | 1997-05-28 |
| HUP9602196A3true HUP9602196A3 (en) | 1998-07-28 |
| HU226134B1 HU226134B1 (en) | 2008-05-28 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9602196AHU226134B1 (en) | 1995-08-11 | 1996-08-09 | Sulfonyl- and sulfinyl-benzoyl-guanidine derivatives and pharmaceutical compositions thereof |
| Country | Link |
|---|---|
| US (1) | US5744641A (en) |
| EP (1) | EP0758644B1 (en) |
| JP (1) | JP3901766B2 (en) |
| KR (1) | KR100447111B1 (en) |
| CN (1) | CN1071743C (en) |
| AR (1) | AR004677A1 (en) |
| AT (1) | ATE252075T1 (en) |
| AU (1) | AU709800B2 (en) |
| BR (1) | BR9603377B1 (en) |
| CA (1) | CA2183050C (en) |
| CZ (1) | CZ292974B6 (en) |
| DE (2) | DE19529612A1 (en) |
| DK (1) | DK0758644T3 (en) |
| ES (1) | ES2206534T3 (en) |
| HU (1) | HU226134B1 (en) |
| MX (1) | MX9603300A (en) |
| NO (1) | NO306858B1 (en) |
| PL (1) | PL184320B1 (en) |
| PT (1) | PT758644E (en) |
| RU (1) | RU2159232C2 (en) |
| SI (1) | SI0758644T1 (en) |
| SK (1) | SK281661B6 (en) |
| TW (1) | TW432039B (en) |
| UA (1) | UA45965C2 (en) |
| ZA (1) | ZA966773B (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4328352A1 (en) | 1993-08-24 | 1995-03-02 | Hoechst Ag | Substituted N, N'-di-benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent, and medicament containing them |
| DE19833118C2 (en) | 1998-07-23 | 2000-07-27 | Merck Patent Gmbh | Process for the preparation of orthoalkylated benzoic acid derivatives |
| DE19903275A1 (en)* | 1999-01-28 | 2000-08-03 | Merck Patent Gmbh | Lyophilisates with improved reconstitutability |
| DE19951418A1 (en)* | 1999-10-26 | 2001-05-03 | Merck Patent Gmbh | Process for the preparation of N- (4,5-bismethanesulfonyl-2-methyl-benzoyl) guanidine, hydrochloride |
| DE10001879A1 (en) | 2000-01-19 | 2001-07-19 | Aventis Pharma Gmbh | New benzoylguanidine derivatives are Na+/H+ exchange inhibitors useful for the treatment and prevention of e.g. ischemic disorders, infarction, arrhythmia, angina pectoris and stroke |
| DE10023405A1 (en)* | 2000-05-12 | 2001-11-15 | Merck Patent Gmbh | Preparation of N-(4,5-bis-(alkanesulfonyl)-2-alkyl-benzoyl)-guanidine salt used as sodium ion-proton antiporter inhibitor, by alkylsulfonylation of 4-substituted benzoate ester, reaction with guanidine and salification |
| KR100643561B1 (en)* | 2000-12-08 | 2006-11-10 | 엘지.필립스 엘시디 주식회사 | Array Board for Liquid Crystal Display and Manufacturing Method of Array Board |
| DE10305070A1 (en)* | 2003-02-07 | 2004-08-26 | Merck Patent Gmbh | Use of sodium-hydrogen ion antiporter 1 inhibitors e.g. N-(4,5-bis-methanesulfonyl-2-methyl-2-methyl-benzoyl)-guanidine, used at doses causing only partial inhibition, e.g. for treating arrhythmia or angina |
| JP2006525247A (en)* | 2003-05-06 | 2006-11-09 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | Method for crystallizing guanidine salts |
| DE102004045825A1 (en)* | 2004-09-22 | 2006-03-23 | Merck Patent Gmbh | Lyophilisate containing N-diaminomethylene-2-methyl-4,5-di (methylsulfonyl) benzamide |
| EP2671576B1 (en)* | 2008-05-09 | 2020-04-08 | Merck Patent GmbH | Pharmaceutical composition for treating diseases associated with insulin resistance and ß-cell dysfunction |
| BRPI0918502A2 (en)* | 2008-09-02 | 2015-12-01 | Sanofi Aventis | substituted aminoindans and analogs thereof, and their pharmaceutical use |
| FR2948028B1 (en) | 2009-07-17 | 2011-12-02 | Merck Sante Sas | ASSOCIATION OF A SODIUM-PROTON EXCHANGER INHIBITOR AND A DIHYDRO-1,3,5-TRIAZINE AMINOUS DERIVATIVE |
| WO2017137147A1 (en)* | 2016-02-08 | 2017-08-17 | Merck Patent Gmbh | Crystalline modifications of n-(4,5-bismethanesulfonyl-2-methylbenzoyl)guanidine hydrochloride and n-(4,5-bismethanesulfonyl-2-methylbenzoyl)guanidine salts |
| EP4230196A1 (en) | 2022-02-21 | 2023-08-23 | Som Innovation Biotech, S.A. | Compounds for use in the treatment of dystrophinopathies |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU616041B2 (en)* | 1988-08-26 | 1991-10-17 | Sumitomo Chemical Company, Limited | A hydrazone compound and production therefor, and an insecticidal composition containing the same |
| DE3929582A1 (en)* | 1989-09-06 | 1991-03-07 | Hoechst Ag | BENZOYLGUANIDINE, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS A MEDICINE AND THE MEDICINE CONTAINING IT |
| ES2097409T3 (en)* | 1992-09-22 | 1997-04-01 | Hoechst Ag | BENZOILGUANIDINES, PROCEDURE FOR ITS PREPARATION, AS WELL AS ITS USE AS ANTIARRHYTHMIC. |
| EP0604852A1 (en)* | 1992-12-28 | 1994-07-06 | Hoechst Aktiengesellschaft | 2,4-Substituted 5-(N-substituted-sulfamoyl) benzoylguanidines, as antiarrhythmic agents, inhibitors of the proliferation of cells and inhibitors of sodium-hydrogen exchange |
| DE4430916A1 (en)* | 1994-08-31 | 1996-03-07 | Merck Patent Gmbh | Alkyl benzoylguanidine derivatives |
| Publication | Publication Date | Title |
|---|---|---|
| IL116851A (en) | 3-arylidene-2-oxindole derivatives and pharmaceutical compositions containing them | |
| IL116917A0 (en) | Piperidine derivatives and pharmaceutical compositions containing the same | |
| IL119078A (en) | Substituted benzylaminopiperidine compounds and pharmaceutical compositions comprising them | |
| IL122485A0 (en) | Arylsulfonylaminobenzene derivatives and pharmaceutical compositions containg the same | |
| NZ304982A (en) | Pyridinyloxy- or pyridinylamino-acetamide derivatives; pharmaceutical compositions | |
| HUS1200028I1 (en) | 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivatives and pharmaceutical compositions containing them | |
| HUP9900424A2 (en) | Thiazolylbenzofuran derivatives and pharmaceutical compositions containing them | |
| HUP0000474A3 (en) | Arylethenesulfonamide derivatives and drug composition containing the same | |
| IL119559A0 (en) | Purin -6- one derivatives their preparation and pharmaceutical compositions containing them | |
| HUP9901344A3 (en) | Radicicol derivatives and pharmaceutical compositions thereof | |
| IL125710A0 (en) | Arylglycinamide derivatives their preparation and pharmaceutical compositions containing them | |
| HUP9802290A3 (en) | Pyrrole derivatives and pharmaceutical compositions containing them | |
| IL122705A (en) | 2-(4-Susbstituted)-benzylamino-2-methyl-propanamide derivatives their preparation and pharmaceutical compositions containing them | |
| AU5856898A (en) | Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them | |
| ZA967800B (en) | Heteroaryllsubstituted acryloylguanidine derivatives and pharmaceutical compositions comprising them | |
| HUP0100085A3 (en) | Biphenylamidine derivatives and pharmaceutical compositions containing them | |
| HUP9602196A3 (en) | Sulfonyl- and sulfinyl-benzoyl-guanidine derivatives and pharmaceutical compositions thereof | |
| HUP0002331A3 (en) | 20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof | |
| IL118427A (en) | N-acyl-2 aryl cycloalkylmethylamine derivatives as melatonergics and pharmaceutical compositions comprising them | |
| IL115113A0 (en) | Pyridinium derivatives and pharmaceutical compositions containing them | |
| HU9500386D0 (en) | Benzodiazepine derivatives and pharmaceutical compositions containing them | |
| GB9501286D0 (en) | Pharmaceutical compositions and preparations thereof | |
| HUP9802291A3 (en) | Penicillaminamide derivatives and pharmaceutical compositions containing them | |
| IL115982A (en) | Cyclolignan derivatives and pharmaceutical compositions containing them | |
| AU3710695A (en) | Quinolonylcarboxyerythromycin derivatives and pharmaceutical compositions containing them |
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of definitive patent protection due to non-payment of fees |